Brown & Brown Earnings Call Transcripts
Fiscal Year 2026
-
Q1 revenue grew 35.4% to $1.9B, with strong cash flow and margin expansion. Organic growth was flat, impacted by property rate declines and a pharmacy consulting model shift, but sequential improvement is expected. AI and technology investments are driving efficiencies and future growth.
Fiscal Year 2025
-
Delivered 23% revenue growth and strong cash flow, driven by M&A and contingent commissions. Integration of Accession is progressing well, while a competitor's team lift poses a $23M revenue risk. Outlook for 2026 is stable, with improved organic growth and raised margin targets.
-
Q3 revenue grew 35.4% to $1.6B with 3.5% organic growth, driven by acquisitions and margin expansion. Retail and specialty segments saw solid performance, though Q4 guidance anticipates headwinds from incentive adjustments and non-recurring revenue. Integration of AssuredPartners is on track.
-
Q2 revenue grew 9.1% to $1.3B with 3.6% organic growth and margin expansion. Accession acquisition is set to close in August, supported by strong equity and debt issuance. Insurance rates are moderating, impacting organic growth, but cash flow and M&A activity remain robust.
-
The acquisition combines two culturally aligned, high-performing insurance platforms, expanding capabilities, scale, and specialty offerings. The $9.8 billion deal is expected to deliver $150 million in synergies by 2028, with integration well underway and minimal regulatory hurdles remaining.
-
Q1 delivered double-digit revenue and earnings growth, with margin expansion and strong cash flow. Cat property rates are declining, but overall insurance pricing remains stable. M&A activity and segment performance were robust, supporting a positive outlook for the year.
Fiscal Year 2024
-
Fourth quarter and full-year results showed double-digit revenue and EPS growth, strong margin expansion, and robust cash generation. Segment performance was led by exceptional growth in programs, while retail and wholesale also delivered solid results. Outlook for 2025 is stable, with flat margins expected and continued M&A activity.
-
Revenue grew 11% year-over-year to nearly $1.2 billion, with strong organic growth and margin expansion across all segments. Programs and Wholesale Brokerage led performance, while Retail growth was impacted by lower incentive commissions. Full-year EBITDA margin is expected to rise at least 100 basis points.
-
The acquisition targets a top five Dutch insurance broker, with a $700M purchase price and projected 2025 revenues of $110–$120M. Integration into European operations is planned, with no earn-out due to local regulations. The deal is expected to be accretive and supports long-term growth.
-
Revenue grew 12.5% year-over-year to nearly $1.2 billion, with 10% organic growth and strong margin expansion across all segments. Guidance calls for 50-100 bps of adjusted EBITDA margin improvement in 2024, contingent on storm activity. M&A activity and cash generation remain robust.